7th Zurich Immuno-Oncology Symposium

The 7th Zurich Immuno-Oncology Symposium will bring together clinicians and scientists across the cancer immunotherapy field to deepen the understanding of cancer, the immune system and immunotherapy.


USZ Kleiner Hörsaal Path C22 & Zoom

The meeting link will be provided to all registered participants prior to the meeting.




9.00 a.m. – 4.30 p.m.




9.00 a.m. Welcome
Markus G. Manz, University Hospital Zurich
Session 1: Patrick Roth
9.05 a.m. Improving TIL-therapy in cancer
George Coukos, CHUV Lausanne
9.30 a.m. PD1 resistant Melanoma: The latest drug developments
Reinhard Dummer, University Hospital Zurich
9.55 a.m. Short Talk: Immunocytokines in non-melanoma skin cancer
Antonio Cozzio, Hospital St. Gallen
10.15 a.m. Synergy of checkpoint inhibition and immuno-stimulation
Mélanie Tichet, Hanahan Lab Lausanne
10.40 a.m. Coffee Break
Session 2: Markus G. Manz
11.00 a.m. T-cell engaging Antibodies in hematologic malignancies
Marion Subklewe, University Hospital Munich 
11.25 a.m. Short Talk: Darpin-based, mulitple antigen-directed T-cell engagers and activators
Nicolas Leupin, Chief Medical Officer Molecular Partners Zurich
11.45 a.m. Short Talk: Combined T-cell engaging and checkpoint inhibiting antibodies in plasma cell neoplasia (LocATE)
Leonardo Borras, Chief Scientific Officer, CDR-Life, Zurich
12.05 p.m. Short Talk: DNA-encoded libraries for discovery of new surface targets
Dario Neri, CEO of Philogen and Professor of ETH Zürich
12.25 p.m. Lunch Break
Session 3: Dominik Schneidawind
1.10 p.m. New targets for CAR-T cells in hematology and oncology
Michael Hudecek, University Hospital Würzburg
1.30 p.m. Universal CAR T-cells: proof of concept studies
Michael Bachmann, HZDR Dresden
1.55 p.m. Short Talk: Academic virus-free CAR T-cell development
Chiara Magnani, University Hospital Zurich
2.20 p.m. Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia with CAR T-Cells
Laura Volta, University Hospital Zurich
2.40 p.m. Coffee Break
Session 4: Felix Beuschlein 
3.05 p.m. Short Talk: Targeted RNA-CAR mediated immunotherapy against glioblastoma
Tobias Weiss, University Hospital Zurich
3.25 p.m. Short Talk: Harnessing macrophage checkpoints to treat cancer
Alexandre Theocharides, University Hospital Zurich
3.45 p.m. Microglia activation against glioblastoma
Gregor Hutter, University Basel
4.10 p.m. Wrap up


The registration is closed. You can still participate online at the following link:

Join Zoom Meeting

Passcode: 704136


Verantwortlicher Fachbereich